EyePoint Pharmaceuticals
EYPT
#8320
Rank
NZ$0.58 B
Marketcap
NZ$7.00
Share price
4.42%
Change (1 day)
-69.24%
Change (1 year)

Earnings for EyePoint Pharmaceuticals (EYPT)

Earnings in 2026 (TTM): -NZ$0.47 Billion

According to EyePoint Pharmaceuticals 's latest financial reports the company's current earnings are NZ$7.61 Million. In 2025 the company made an earning of -NZ$0.41 Billion a decrease over its 2024 earnings that were of -NZ$0.25 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for EyePoint Pharmaceuticals from 2003 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$0.47 Billion14.47%
2025 -NZ$0.41 Billion63.24%
2024 -NZ$0.25 Billion104.29%
2023 -NZ$0.13 Billion-29.88%
2022 -NZ$0.18 Billion87.2%
2021 -NZ$92.17 Million38.58%
2020 -NZ$66.51 Million-24.56%
2019 -NZ$88.16 Million
2017 -NZ$40.21 Million22.59%
2016 -NZ$32.8 Million-8.02%
2015 -NZ$35.66 Million-296.09%
2014 NZ$18.18 M-174.02%
2013 -NZ$24.57 Million37.42%
2012 -NZ$17.88 Million-56.29%
2011 -NZ$40.9 Million-1062.38%
2010 NZ$4.24 M-250.43%
2009 -NZ$2.83 Million-89.5%
2008 -NZ$26.92 Million
2005 -NZ$16.6 Million56.99%
2004 -NZ$10.58 Million73.7%
2003 -NZ$6.09 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Nymox Pharmaceutical
NYMX
-NZ$3.77 Million-99.20% Bahamas
NRC Health
NRC
NZ$34.16 M-107.26%๐Ÿ‡บ๐Ÿ‡ธ USA